Autoimmune diabetes induced by PD-1 inhibitor—retrospective analysis and pathogenesis: a case report and literature review-Reference-Cited by-同舟云学术

Autoimmune diabetes induced by PD-1 inhibitor—retrospective analysis and pathogenesis: a case report and literature review

Published:2017-06-20 Issue:11 Volume:66 Page:1399-1410
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Gauci Marie-Léa,Laly Pauline,Vidal-Trecan Tiphaine,Baroudjian Barouyr,Gottlieb Jérémy,Madjlessi-Ezra Nika,Da Meda Laetitia,Madelaine-Chambrin Isabelle,Bagot Martine,Basset-Seguin Nicole,Pages Cécile,Mourah Samia,Boudou Philippe,Lebbé Céleste,Gautier Jean-François

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-017-2033-8/fulltext.html

Reference25 articles.

1. Robert C, Long GV, Brady B et al (2015) Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372:320–330. doi: 10.1056/NEJMoa1412082

2. Wang J, Yoshida T, Nakaki F et al (2005) Establishment of NOD-Pdcd1−/− mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci USA 102:11823–11828. doi: 10.1073/pnas.0505497102

3. Rajasalu T, Brosi H, Schuster C et al (2010) Deficiency in B7–H1 (PD-L1)/PD-1 coinhibition triggers pancreatic β-cell destruction by insulin-specific, murine CD8 T-cells. Diabetes 59:1966–1973. doi: 10.2337/db09-1135

4. Guleria I, Gubbels Bupp M, Dada S et al (2007) Mechanisms of PDL1-mediated regulation of autoimmune diabetes. Clin Immunol 125:16–25. doi: 10.1016/j.clim.2007.05.013

5. Hansen E, Sahasrabudhe D, Sievert L (2016) A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome. Cancer Immunol Immunother 65:765–767. doi: 10.1007/s00262-016-1835-4

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrinopathies Associated With Immune Checkpoint Inhibitor Use;Endocrine Practice;2024-06

2. Pembrolizumab autoimmune related diabetes: Moving forward, keep learning;World Journal of Clinical Oncology;2024-05-24

3. Case report: Strong GAD antibody positivity and type 1 diabetes-HLA-susceptible haplotype-DRB1*04:05-DQB1*04:01 in a Japanese patient with immune checkpoint inhibitor-induced type 1 diabetes;Frontiers in Endocrinology;2024-05-22

4. Challenges in autoimmune polyendocrine syndrome type 2 with the full triad induced by anti-programmed cell death 1: a case report and review of the literature;Frontiers in Immunology;2024-04-18

5. The Development of Diabetes and Diabetic Ketoacidosis Following Immunotherapy Treatment: A Systematic Review of Case Reports;Cureus;2024-04-09